AKESOgen Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- AKESOgen's estimated revenue is currently $5.7M per year.
- AKESOgen's estimated revenue per employee is $143375
- AKESOgen has 40 Employees.
- AKESOgen grew their employee count by 25% last year.
- AKESOgen currently has 1 job openings.
|Mark Bouzyk||Co-Founder & Chief Scientific Officer|
|Maria Mikkelson||Vice President Information Technology|
|Kevin Robson||Director Of Business Development|
|Lauren McGoldrick||Vice President of Project Management|
|Rachel Crossen||Senior Director, Business Development, Genomic Services|
|Robert Boisjoli||Chief Executive Officer /founder|
|Gabriela Oprea-llies||Laboratory Medical Director|
|Barbara Glazer||Director, Compliance & Clinical Trial Project Management.|
What Is AKESOgen?
AKESOgen is a biomarker, genomics and pharmacogenomics CRO company that services the academic, pharmaceutical, biotechnology and agricultural sectors. The company is based in Atlanta, GA, USA. AKESOgen performs biomarker profiling and genomics services (e.g. next generation sequencing and genotyping) utilizing different types of markers (e.g. DNA, mRNA, miRNA, methylation) for the R&D market. AKESOgen establishes and validates biomarkers in the Clinical Trials arena. AKESOgen has expertise in Biobanking.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
NEW YORK, Feb. 13, 2019 /PRNewswire/ -- RenalytixAI (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney ...
LONDON (Alliance News) - Renalytix AI PLC on Wednesday said it has entered into a partnership agreement with laboratory facility provider ...
“AKESOgen brings a state-of-the-art CLIA-certified and CAP-accredited laboratory facility that enables RenalytixAI to immediately scale ...